The problem

Companies dedicate lots of time and resources to innovating breakthrough products, yet a large majority of consumer packaged goods product launches fail: estimates suggest up to 90%. Solutions for mapping markets, consumer patterns and their complex relationships can help uncover new insights and support the creative thinking needed for successful innovation.

The solution

Klydo has developed a tool that provides innovation insights using artificial intelligence (AI). Its platform provides consumer brands with the market intelligence needed to accelerate product innovation, by using algorithms that enable a quantitative approach in what is traditionally qualitative research.

The technology aims to support and enhance creative thinking in any team. It works by combining machine learning with data visualisation to bring existing online information to life in creative and user-friendly ways.

Current approaches to market research can be expensive and time-consuming, typically lasting two to three months. Klydo’s technology works in real-time to offer differentiating perspectives, reveal unmade connections, and expose patterns and trends. This helps companies to more easily and efficiently build new products, make smarter, strategic decisions and improve innovation roadmapping.

Nick Schweitzer, CEO and Co-Founder, got the idea to develop the technology based on an interest in how to engineer the creative spark behind innovation. Klydo’s technology brings together diverse interests and expertise in fields such as design thinking, psychology and AI. It currently sells to leading brands such as Unilever, with others in line to trial the platform.

Traction

• 2018: successfully closed a seed investment round that attracted high-profile investors in both ‘deep tech’ and consumer branding.

Nick Schweitzerwas awarded a 2018 Enterprise Fellowship to continue developing the technology and support a growing team at Klydo. Klydo is also supported by Venture Capitalists Episode 1 and True.

The problem

There are 1.2 million wheelchair users in the UK and children are the fastest-growing user group. For many wheelchair users, comfort and independent use is restricted because of poor postural support.  

Poor posture impacts a child’s ability to breathe, swallow and communicate, affecting physical health and deterring them from socially engaging with the world comfortably and independently. There are over 70,000 young wheelchair users in the UK and parents with a disabled child spend an average of £200 million annually on specialist equipment.

The solution

Aergo has developed responsive, postural support seating for young wheelchair users. It uses pressure-sensitive inflatable supports that react to a user’s position to reinforce posture.

Aergo’s cost-effective solution works by inflating or deflating separate cells to achieve a natural and responsive form of support. Controlled either by the user or automatically, the technology increases independence by reducing the need for manual repositioning.

Current solutions are bulky and expensive. Some use straps and wedges to fix users into a single position, which restrict movement. This can lead to poor blood circulation and an increased likelihood of developing pressure ulcers. For children with cerebral palsy, scoliosis and paraplegia, Aergo posture support is adaptable for use in a variety of chairs and buggies, and expands in width for longer-term use.

Working with a special educational needs school inspired Sheana Yu, Founder and CEO, to find better ways to support children to interact with their environment. This led to the development of the seating technology, Sheana now leads the startup in finalising designs to comply with safety standards. The aim is to launch Aergo seating to market by 2020.

Traction

• 2015: Raised seed investment from UK Angels.
• 2016: Collaboration with Alder Hey Children’s hospital for testing and clinical feedback.
• 2018: Collaboration with Xcellent Manufacturing Co. for production set-up.
• 2018: Received an AXA Women Entrepreneur in Healthtech Award and featured in the Nesta Inventor Prize Top 10.
• 2019:  Received a Women in Innovation Award from Innovate UK. 

Sheana Yu was awarded the 2018 Enterprise Fellowship to continue developing this technology and her startup Aergo.

The problem

Over 70% of the world’s coastlines experience erosion, which is increasing at an exponential rate due to climate change. Coral reefs provide valuable ecosystems that naturally prevent this erosion, but these are also rapidly being lost globally. 

The solution

Zyba Ltd has developed CCell, a technology that uses wave energy to create artificial coral reefs in any shape or size. This can provide a long-term, ecological solution to coastal erosion, restoring fisheries and enhancing tourism in the process by creating new scuba dive sites.

CCell technology is an ultra-lightweight energy converter that uses ocean waves to generate electricity. This is used to power BioRock – a process of electrolysis that makes sea minerals form around a steel structure, effectively creating a reef. The process enables corals to grow up to five times faster than they would naturally.

Many coastal regions such as those in Indonesia, the Dominican Republic and Mexico rely heavily on tourist income. Governments and the hotel industry absorb the high costs of coastal protection and many current solutions are both temporary and, in some cases, can increase erosion rates over time.

CCell has gained significant interest in Mexico where local partners have been supporting pilot projects to demonstrate the benefits in this key market. Future plans include scaling up the technology to increase access to a market that is valued at £16 billion globally. Tara Massoudi leads Business Development at Zyba Ltd and is responsible for developing the partnerships that will support the growth of the company and the implementation of its core technology, CCell.

Traction

• 2015: Innovate UK and Engineering and Physical Sciences Research Council award of £1.8 million to accelerate the development of CCell.
• 2018: First pilot unit installed in a test site in Mexico. 
• 2019: Zyba Ltd enters a collaboration with the National Commission of Natural Protected Areas Mexico to explore the potential impact of CCell and validate the technology. 

In 2018, Tara Massoudi was awarded an 1851 Royal Commission Enterprise Fellowship to support Zyba as it expands and brings its technology to market. Zyba Ltd has also been supported by Innovate UK as well as the EU Commission as part of a Horizon 2020 project.

The problem

Drones can be used to significantly reduce time, cost and risk of structural surveying and inspection, but they generate large quantities of image-related data that can be costly and resource-intensive to process.

The solution

TRIK has developed software that makes drone use for surveying and inspection more accessible. It takes photos and videos captured by drones and automatically turns them into an interactive 3D model that acts as a twin of the real structure.

The technology opens up new possibilities for engineers to visualise sites and structures. Its interactive 3D models can be used to generate insights and also double as a database. They can be used for fast and efficient search, measurement, analysis and comment without the need to visit the actual structure.

It can make drone photography more efficient with processes for auto-tagging images and mapping changes across time. This supports surveyors, asset managers and engineers by making it easier to detect structural changes, predict failure, evaluate risk and maintain sites.

Drone-related services are projected to grow dramatically in the next five years. For example, growth for drone software in asset monitoring and inspection is predicted to reach $7.5 billion by 2022.

Led by Dr Pae Natwilai, an innovator selected for the Forbes 30 Under 30 Europe Industry list in 2018, TRIK is working with companies to scale its systems and impact the global market for drone software. It aims to achieve this by making drone survey and inspection more accessible, without the need for significant technical expertise.

Traction

• 2017: Dr Natwilai was awarded the Design in Innovation Award by Innovate UK.
• 2018: TRIK accepted into the Geovation programme to support development of the startup.
• 2018: Trik listed as one of the 10 Most Innovative Aviation and Aerospace Solution Providers by Insights Success. 

Dr Natwilai was awarded a 2018 Enterprise Fellowship to support her in bringing TRIK’s solutions to market. TRIK is also funded by Zoopla founder, Alex Chesterman, and LoveFilm founder, Simon Franks.

The problem

The ability to manipulate sound waves could lead to new opportunities and products in a wide range of sectors, from medical imaging to improved building acoustics. Achieving this is a challenge as many current technologies are large, inefficient and expensive.

The solution

Metasonics’ new technology can focus, sculpt and direct soundwaves in real time, bringing enhanced control and new functionality to sound.

Similar to how a projector transforms a single light beam into a vast and varied image, the technology can make a single speaker sound like hundreds of individual speakers. It uses acoustic metamaterials, and is a cost-effective, compact and scalable solution with the potential to disrupt a range of sectors.

The patented technology easily and flexibly manipulates sound and can be adapted to different contexts and environments. It also has lower power consumption, so increases the applications of a single device.

Sectors that could benefit include building and architecture where the technology can be used for effective sound insulation. Metasonics filters (such as sound-proof windows) are suitable for places where light and air flow are beneficial, yet external noise levels are an obstacle.

It could also improve ultrasonic testing for non-destructive safety evaluation in structures such as bridges, aircrafts and power stations. The ultrasound technology also opens up new possibilities in medical therapies and diagnostics. Metasonics’ solutions can improve the quality and detail in non-invasive imaging and help to tailor therapies such as high-intensity-focused ultrasound, which is used to reduce tumours and in various fat reduction and plastic surgeries.

Metasonics initial market focus is silence through smart engineering within the automotive sector. Its technology can provide more effective and efficient control strategies to help improve comfort and sound insulation inside a vehicle cockpit.

In consumer or other more complex markets, Metasonics’ technology shares a common goal: increase efficiency and cost reduction for end users. Current and future products encompass proprietary designs, which yield substantial benefits over competitive products, enable new applications and open up new markets.

Dr Mihai Caleap, CEO, has a multidisciplinary background and leads the startup in optimising designs and prototyping with a view to creating the first spatial sound modulator for shaping and manipulating sound.

Traction

• 2018: Launches its technology at global tech conference CES in Las Vegas.
• 2018: Awarded ‘Best Hardware’ and ‘Most Innovative use of Tech’ at the SPARKies awards.
• 2018: Selected as one of Hello Tomorrow’s Top 500 deep-tech startups worldwide in Industry 4.0.
• 2018: Recognised by Tech Nation as one of the UK’s most exciting tech startups and named as one of the top three technology startups in the South West.

Dr Caleap was awarded a 2018 Enterprise Fellowship to provide him with time to develop Metasonics’ technology and support the company’s growth.

The problem

Minimally invasive surgery offers significant benefits over conventional surgery. Smaller incisions lead to faster healing times and improved patient outcomes. However, these intricate procedures can be challenging to perform. Up to one in six surgeries still result in complications, many of which could be prevented by using better surgical planning tools.

The solution

Innersight’s 3D modelling technology can be used by surgeons to improve operative planning. It uses medical scans to create interactive, 3D models of a patient’s anatomy. Surgeons can then refine these models, using interactive artificial intelligence tools, to plan surgeries and visualise potential risks.

The technology uses deep learning algorithms to create accurate models that can be viewed on mobile devices, used in virtual reality or 3D printed. Innersight’s solutions are web-based, allowing surgeons to build and view models from any computer with an internet connection without installing specialised software.

Their retrospective clinical study has shown that the technology has helped surgeons adapt their approach in up to one in five cases. This leads to better informed decisions about, for example, which vessels to clamp or the right area for tissue incision. By reducing the risk of complications, the technology will help patients to have shorter hospital stays and save healthcare providers money.

Dr Eoin Hyde, CEO, draws on significant experience in computational physiology and the development of medical devices, as he leads Innersight towards making its technology widely available.

From abdominal and thoracic soft-tissue operations to orthopaedics and cardiac surgeries, Innersight is expanding its products to capture a share of the global minimally invasive surgery market, currently valued at $40 billion.

Traction

• 2019: Ethical approval granted for a prospective study hosted at the Royal Free Hospital, London. Innersight included as one of 10 SMEs to partner with the new London Medical Imaging and Artificial Intelligence Centre for Value-Based Healthcare
• 2017: Awarded funding from the MedCity Collaborate to Innovate and National Institute for Health Research Invention for Innovation Connect programmes
  
• 2016: Won the London Business School Healthtech Challenge
• 2015: Awarded Innovate UK Smart award for proof-of-concept

Dr Hyde was awarded a 2018 Enterprise Fellowship to support him as he leads Innersight in bringing its solutions to market.

The problem

Flexible, transparent electronics are increasingly in demand to support advances in electronic technologies. However, developments in materials science currently limits the availability of materials with the right properties.

The solution

Graphexe Nanotechnology have used graphene to create an ultra-thin, flexible and transparent material known as GraphExeter. The material has a distinctive combination of properties – it is as conductive as metal and as flexible as plastics. This creates new possibilities for advances in electronics in areas such as flexible lighting, foldable screens and other display technologies.

As a researcher with expertise in two-dimensional materials, Dr Liping Lu is helping Graphexe Nanotechnology to design integrated manufacturing processes for consistent and reliable production. The aim is to draw on the material’s properties to make it in a cost-effective and environmentally sustainable way.

Graphexe Nanotechnology is working in partnership with leading technology companies to refine and develop the use of its material in a range of new devices. This includes collaborations with Cambridge Display Technology, a leading developer of flexible lighting, and BOE, a global leader in manufacturing displays for mobile phones, tablets, televisions and other consumer electronics.

As Graphexe Nanotechnology grows in scale, with support from its partners its focus is to target the display technology and OLED-based lighting industry, which has a projected value of $10 billion by 2028.

Traction

• Collaborations started with leading technology firms Cambridge Display Technology (2015) and BOE (2017).

Dr Lu was awarded a 2018 Enterprise Fellowship to further develop Graphexe Nanotechnology.

The problem

Balancing electrical supply with consumption is a challenge for power grids. An added difficulty is maintaining the balance across different timescales – from milliseconds to seasons. Sustainable grid management solutions need to manage intermittent supply from sources, including renewables. New technologies with long-term durability are needed to manage these demands.

The solution

Gyrotricity Ltd, a spin out from City, University of London, has developed a new technology for kinetic energy storage. . The technology is based on a flywheel, a steel rotor that stores energy that can be converted to electrical energy and released quickly on demand.

Gyrotricity’s flywheel is made using thin layers of laminated steel. As a result, it is more durable and safer than single-mass steel flywheels, as any potential damage can be easily contained. The company has also designed an electrical motor generator that lasts for up to 25 years, and is used for transmitting and retrieving power from the flywheel. Combined, the systems provide a lightweight and cost-effective solution to energy storage in the grid.

The Gyrotricity flywheel has two to four times greater energy density than conventional steel flywheels. High power, at the megawatt scale, can be provided by having flywheels connected in banks in containers. Gyrotricity is currently designing and testing these in the laboratory and at customer sites.

Professor Keith Pullen, Chief Technical Officer, holds the patents for the laminated flywheel technology. He draws on over twenty years of expertise in the field as he supports Gyrotricity in bringing its solutions to market.

Traction

• 2017:  Rail Safety and Standards Board funded development of the Gyrotricity flywheels in rail.
• 2018: Awarded funding from the Department for Business, Energy and Industrial Strategy Energy Entrepreneurs Fund.

Professor Pullen was awarded a 2018 Enterprise Fellowship to support him in refining Gyrotricity’s flywheel technology and bringing it to market.

The problem

Simulations can provide insights and analyses that transform and optimise businesses across sectors. Yet creating simulations is a highly specialised task that requires expensive software and hardware as well as expertise in network analysis, physics and software engineering. This means that many companies find it challenging to access.

The solution

Slingshot Simulations aims to make simulation and data analytics more accessible through its user-friendly simulation service. The automated, integrated cloud-based service is a fast, cost-effective route to accurate simulation.

Slingshot uses a patent-pending optimisation technique for automated analysis of big data. The technology is based on over a decade of research and development, in close collaboration with industry. It can quickly handle large amounts of data to create real-time simulations for use in forecasting and analysis.

Dr David McKee was closely involved in the development of the technology as the company’s Lead Technological Architect while at the University of Leeds. As CTO, David leads the company as it extends its scalable platform for companies in sectors including logistics, real estate, city planning, sustainable design and insurance.

The insights gained by more cost-effective, readily-accessible simulation services have been shown to improve clients’ market share by 2% to 3%. With such potential to influence business, Slingshot simulations is well placed to impact the global simulation market, currently valued at $6.5 billion.

Traction

• 2013 to 2018 – Funding awarded by the Engineering and Physical Sciences Research Council and Jaguar Land Rover for research and development.
• 2017 – Collaboration with IMC Business Architectures, Canada a leading company in artificial intelligence solutions.

Dr McKee was awarded a 2018 Enterprise Fellowship to further develop University of Leeds spin-out, Slingshot Simulations. 

David Lane is Professor and Founding Director in the Edinburgh Centre for Robotics, a joint venture between Heriot-Watt and Edinburgh Universities. 

Previously he established Heriot-Watt’s Ocean Systems Laboratory with an international reputation in marine robotics. He has been a visiting Fellow at the Woods Hole Oceanographic Institution USA, visiting Professor at Florida Atlantic University, Scientific Advisor to the NATO Undersea Research Centre, La Spezia Italy, Development Engineer with the former Ferranti Ltd and Diver-Maintainer with British Oceanics (now Subsea7).

In 2013 he chaired the InnovateUK RAS-SIG committee leading development of the UK’s RAS2020 national robotics innovation strategy and sits on the Advisory Board of the 8 Great Technologies Venture Fund, BAe Systems Corporate Foresight Panel and the UK Atomic Energy Authority Programme Advisory Committee. 

David Chairs the RSE Enterprise Fellowship and B3 Engineering Fellowship Selection Committees, is a member and mentor in the RAEng Enterprise Fellowship Programme, a member of the EPSRC Engineering Strategic Advisory Team (SAT) and RAEng Finance Committee. 

He has been elected to fellowship of the Royal Academy of Engineering (2012), Royal Society of Edinburgh, Institution of Engineering and Technology, Society of Underwater Technology and Royal Geographical Society. He was appointed Commander of the Order of the British Empire for services to Engineering in the 2016 Queen’s New Year Honours list.

Douglas has a 40 year business career covering almost every aspect, at every level, of healthcare technology product design and product commercialisation processes.

Having trained in Industrial Design Engineering (Edinburgh Napier University 1974), Douglas progressed from hands on designer to the management of design in the high tech arena.

Using his company Crombie Anderson as a base for innovation and incubation, he subsequently spun out three other high-tech start -up companies of which two became publicly traded business operating in medical fields.

Douglas is the prime mover in these businesses by leading both the innovation and commercialisation processes, including raising over £40million in private and institutional funding. Today he is internationally recognised for his innovation and entrepreneurial experience and is a regular keynote speaker at healthcare and business congresses around the world.

In 1990, his 5yr old son Leif suffered a spontaneous retinal detachment that went undetected until it was too late to treat. Douglas was struck by the limited capability of diagnostic tools available to clinicians and decided to address this issue. He built a dedicated research team, which led to the formation of Optos plc, a business funded by Archangel from the outset.

Optos succeeded in designing and patenting  a scanning laser ophthalmoscope: the world's first ophthalmic device  that enabled eye care practitioners to capture a digital ultra wide-field image of the retina in a single scan. The new method of examining the retina, marketed as the optomap® Retinal Exam, is now offered as the preferred standard of care by 11,500 eye-care specialists in Europe and the US. Over 70 million optomap® retinal exams have been conducted worldwide already, with a scanning range of approximately 82 per cent of the retina - a huge improvement on the 5-30% of conventional examination techniques.

Douglas was elected a Fellow of the Royal Academy of Engineering (FREng) in 2013.

Sir Peter Bonfield is a leading international business executive with over forty-five years experience in the fields of electronics, computers and communications. Change management in international technology companies has been at the centre of his long and illustrious career.

Since 2002 Sir Peter has been involved with a diverse portfolio of companies and is currently operating at main Board level or director of several companies in the USA, Europe and the Far East. He has served in the past as CEO of ICL and more recently of BT Group.

He is a Fellow of the Royal Academy of Engineering (1993), the Institution of Engineering and Technology, the British Computer Society, the Chartered Institute of Marketing, the Marketing Society and the Royal Society of Arts.

Sir Peter is a Liveryman of The Worshipful Company of Information Technologists, Freeman of the City of London, Honorary Citizen of Dallas, Texas and Member of The Pilgrims of Great Britain.

John is the Director of the Cambridge Engineering Design Centre following a seven-year spell with PA Consulting Group's Technology Division where he was Manager of the Advanced Process Group. He was appointed director of the Engineering Design Centre in 1997 and a University Professor in 2004.

At PA John gained wide experience of product development with a particular focus on the design of medical equipment and high-integrity systems, where clients required a risk-based systems approach to design to ensure timely delivery of safe systems. John is directly involved in the teaching of design at all levels of the undergraduate course.

His research interests are in the general area of engineering design, particularly the development of design methodologies to address specific design issues, for example, process management, change management, healthcare design and inclusive design. As well as publishing over 800 papers, he has written and edited a number of books on medical equipment design, inclusive design and process management.

John is currently leading a team with the Royal Academy of Engineering, the Royal College of Physicians and the Academy of Medical Sciences to develop a systems approach to healthcare redesign and continuous improvement. He was made Fellow of the Royal Academy of Engineering in 2012.

Bill is a leading scientist worldwide in the field of Medical Materials. His major research contributions have been recognised by numerous international awards, medals and memberships.

He has been the Professor of Medical Materials at the University of Cambridge; served as Director of Cambridge Pfizer Institute for Pharmaceutical Materials Science; Cambridge Director of CMI Interdisciplinary Research Cluster in Biomaterials and Tissue Engineering and Director of University of London Interdisciplinary Research Centre (IRC) in Biomedical Materials. He has been Head of Department, Dean, and Governor at Queen Mary University of London. 

He has been the editor of the Journal of The Royal Society: Interface, the Journal of Materials Science: Materials in Medicine, the Journal of Materials Science, and of the Journal of Materials Science Letters.

Bill is Emeritus Professor of Medical Materials in the University of Cambridge. He is internationally recognised for his pioneering research contributions to biomaterials for medical devices, with awards including the Royal Academy of Engineering Prince Philip Gold Medal; the Royal Society Armourers and Brasiers Company Medal; the Kelvin Medal; the European Society for Biomaterials George Winter Award; the Japanese Society for Biomaterials Medal; the Institute of Materials Griffiths Medal and Chapman Medal; the UK Society for Biomaterials President's Prize; the Acta Metallurgica H.H. Holloman Award and the International Union for Physical Sciences and Engineering in Medicine Award of Merit. 

Professor Bonfield's exceptional interdisciplinary contribution has been recognised by his election to all three UK National Academies as a Fellow of the Royal Society (FRS), a Fellow of the Royal Academy of Engineering (FREng) and a Fellow of the Academy of Medical Sciences (FMedSci).

Professor Joe McGeehan completed his PhD in 1971 and since then has been instrumental in many aspects of research and teaching in the field of Communications. He is even referred to as the 'godfather of mobile communications'.

Joe has been conducting research and development into mobile communications technologies and systems since 1973. Working with colleagues, he has pioneered many of the major developments in the field including: deterministric ray-tracing for propagation prediction and network coverage; linear modulation techniques and systems; linearised RF power amplifiers; SMART antennas; wideband CDMA for 3G; WLAN technologies and 60GHz propagation and communication systems.  

Professor McGeehan's achievements in research have been acknowledged by membership of a number of national and international committees in the field of Communications, external examiner positions and mentoring of start-up companies. 

His involvement in Communications over several decades led to being awarded in the Queens Birthday Honours 2004 a CBE for ‘services to the Communications Industry’. Joe was elected a Fellow of the Royal Academy of Engineering in 1994 and was listed in 2004 as No.6 in the world’s ‘Technology AgendaSetters’ by silicon.com (USA) (N.B., Bill Gates was placed No.2).

Billy's vision is to change the way we currently diagnose and monitor serious disease. He is the co-founder of Owlstone, which aims to become the global leader in the non-invasive detection of cancer, infectious disease and inflammatory disease. 

It is best to detect disease as early as possible: treatments are more effective, less involved and more lives can be saved. There is no better example of this than with cancer. If detected early, the chances of cancer survival can be as good at 95%. But this drops massively to about 5% at later stages. Unfortunately there are still far too many people detected at later stage. 

To address this, Owlstone Medical has developed a breathalyzer for disease. Every time you breathe out there are hundreds of chemicals on your breath. Some are telltale markers of disease, which Owlstone microchip chemical sensor technology is able to detect. Through early detection Owlstone have set a goal to have saved 100,000 lives and $1.5 billion in health care costs by 2020.

Since co-founding Owlstone, Billy has been overseeing the development and implementation of the detection technology with nanotechnology foundry partners and is heavily involved in the creation and realisation of new technologies and IP.  He is also active in business development, demonstrating how the Owlstone technology can be a paradigm shift in detection applications and deployment scenarios. 

Prior to his time at Owlstone Billy was a Research Associate in the Microsystems and Nanotech group at Cambridge University. In an academic / industry consortium he designed and developed silicon-opto hybrid devices for next generation telecoms systems.

Cliff is a physicist with interests in soft matter, liquid crystals, displays, optoelectronics and photonics. Acknowledged as an inspirational technical leader and strategist, inventor and innovator, entrepreneur and public speaker, he is an experienced and award winning Chief Technology Officer, company founder and director. Cliff is currently a Professor of Physics; EPSRC Fellow of Advanced Manufacturing at the University of Leeds.

He is experienced in raising venture capital, growing ZBD Solutions Limited from nothing to over $30M sales per annum, becoming Europe's second fastest growing technology company for 2012. 

Professor Jones is a Fellow of the Royal Academy of Engineering, Chartered Physicist and Fellow of the Institute of Physics, Fellow of the Royal Society for the Encouragement of Arts, Manufactures and Commerce, and Senior Member of the Society for Information Display.

Professor Mark Tooley is Head of the Department of Medical Physics & Bioengineering and Director of Research and Development at the Royal United Hospitals, Bath. He is a registered Consultant Clinical Scientist. He is a visiting professor at the University of Bath, and the University of the West of England. He retires from the NHS in the summer of 2017.

Mark completed his BSc in Electrical and Electronic Engineering at the University of Bath in 1979. He was sponsored by Westinghouse Brake and Signal company for the four years of the course. He then did an MSc and PhD in Medical Physics at the University of London. His MSc thesis was developing a EEG frequency analyser for anaesthesia. For his PhD research, Mark invented (with a cardiologist) an original method for rate-independent diagnosis of cardiac rhythm for implantable devices, which was patented.  He spent the rest of his career in Medical Physics and Bioengineering departments, both in hospitals and academia, working along medical colleagues. He has worked at St Bartholomew’s hospital in London, Bristol University, United Bristol healthcare NHS Trust, and the Royal United Hospital, Bath. He is a Fellow of the Royal College of Physicians (RCP), the Institute of Engineering and Technology (IET, formally IEE), the Institute of Physics and Engineering in Medicine (IPEM), and the Institute of Physics (until 2016). He is a Chartered Engineer and Chartered Scientist. Mark is on the peer-review college of EPSRC, has recently a member of the EPSRC Healthcare Technologies Strategic Advisory Team. He was recently on the Royal Society fellowship panel. He is a Fellow of the Royal Academy of Engineering.

Mark has been a long standing member of the Panel for Biomedical Engineering at the Royal Academy of Engineering, is a member of one of their membership panels, a member of the Policy Committee, and on the working group for System Thinking in Healthcare.  He has mentored on the enterprise scheme. 

Mark’s research interests include:  innovations in medicine, physics applications in anaesthesia, simulation in medicine, physiological measurement, biological signal processing, measuring the depth of anaesthesia, blood pressure measurement and novel patient monitoring solutions.